Stock Under $10 with 50-100% upside potential - 14 Days FREE!
EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stock Under $10 that he thinks could potentially double or triple in the next 6 to 12-months. See what he's trading today with a 14-day FREE pass.

Endo Pharmaceutical Holdings Inc. (ENDP): Today's Featured Health Care Loser

Endo Pharmaceutical Holdings (ENDP) pushed the Health Care sector lower today making it today's featured Health Care loser. The sector as a whole closed the day up 1.3%. By the end of trading, Endo Pharmaceutical Holdings fell 24 cents (-0.8%) to $29.88 on heavy volume. Throughout the day, 3.1 million shares of Endo Pharmaceutical Holdings exchanged hands as compared to its average daily volume of 1.4 million shares. The stock ranged in price between $29.75-$30.42 after having opened the day at $30.10 as compared to the previous trading day's close of $30.12. Other company's within the Health Care sector that declined today were: NPS Pharmaceuticals (NPSP), down 11.9%, ImmunoCellular Therapeutics (IMUC), down 11.9%, Urologix (ULGX), down 11.7%, and Strategic Diagnostics (SDIX), down 7.2%.

Endo Health Solutions Inc. provides specialty healthcare solutions in the United States and internationally. Endo Pharmaceutical Holdings has a market cap of $3.62 billion and is part of the drugs industry. The company has a P/E ratio of 90.9, equal to the average drugs industry P/E ratio and above the S&P 500 P/E ratio of 17.7. Shares are down 10.8% year to date as of the close of trading on Thursday. Currently there are 13 analysts that rate Endo Pharmaceutical Holdings a buy, no analysts rate it a sell, and seven rate it a hold.

TheStreet Ratings rates Endo Pharmaceutical Holdings as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth and expanding profit margins. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, generally poor debt management and disappointing return on equity.

On the positive front, Molina Healthcare (MOH), up 26.4%, Stereotaxis (STXS), up 17.4%, Unilife Corporation (UNIS), up 13.8%, and ProPhase Labs (PRPH), up 12.9%, were all gainers within the health care sector with Alexion Pharmaceuticals (ALXN) being today's featured health care sector winner.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider Health Care Select Sector SPDR (XLV) while those bearish on the health care sector could consider ProShares Ultra Short Health Care (RXD).

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
TRY IT FREE

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Dividend Stock Advisor
TRY IT FREE
New! $49.95/yr

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREE

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Real Money
TRY IT FREE

24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.

Product Features:
  • Jim Cramer + 20 Wall Street pros
  • Intraday commentary & news
  • Real-time trading forum
  • Actionable trade ideas
Real Money Pro
TRY IT FREE

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass + 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
TRY IT FREE

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
DOW 15,303.10 8.60 0.06%
NASDAQ 3,459.14 -0.28 -0.01%
S&P 500 1,649.60 -0.91 -0.06%
US 10 Yr 2.011% -0.012

Brokerage Partners

Top Rated Stocks Top Rated Funds Top Rated ETFs